Coya Therapeutics (COYA) Stock: Why It's Up Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $4.32 as of 12:05 PM ET, +1.76% vs the prior close of $4.25.
- Volume 31.41K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
COYA rises 1.8% to $4.32. Trading at $4.32 (intraday, 12:05 PM ET), +1.76% vs the prior close of $4.25. Day range $4.26–$4.53, opened at $4.29.
COYA daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — COYA rises 1.8% to $4.32
- Trading at $4.32 (intraday, 12:05 PM ET), +1.76% vs the prior close of $4.25. Day range $4.26–$4.53, opened at $4.29.
- Volume was 31.41K shares, 0.2x its 50-day average of 131.68K — lighter than usual.
- Price is -9.0% vs its 50-day average ($4.75) and -7.8% vs its 200-day average ($4.69).
- 52-week range $3.71–$7.55; the current price sits at 16% of that range, 42.7% below the 52-week high.
Oct 16, 2026 — COYA dips 2.1% to $4.25
- Closed at $4.25, -2.07% vs the prior close of $4.34. Day range $4.18–$4.39, opened at $4.39.
- Volume was 134.19K shares, 1.0x its 50-day average of 133.99K.
- Price is -10.7% vs its 50-day average ($4.76) and -9.5% vs its 200-day average ($4.70).
- 52-week range $3.71–$7.55; today's close sits at 14% of that range, 43.7% below the 52-week high.
Oct 15, 2026 — COYA jumps 3.8% to $4.34 on 1.8x normal volume
- Closed at $4.34, +3.83% vs the prior close of $4.18. Day range $4.14–$4.50, opened at $4.18.
- Volume was 236.50K shares, 1.8x its 50-day average of 131.25K — unusually heavy trading.
- Price is -9.0% vs its 50-day average ($4.77) and -7.7% vs its 200-day average ($4.70).
- 52-week range $3.71–$7.55; today's close sits at 16% of that range, 42.5% below the 52-week high.
Oct 14, 2026 — COYA slides 6.6% to $4.18, a 1-month low on 2.0x normal volume
- Closed at $4.18, -6.59% vs the prior close of $4.47. Day range $4.16–$4.64, opened at $4.64.
- Volume was 258.00K shares, 2.0x its 50-day average of 129.01K — unusually heavy trading.
- Price is -12.4% vs its 50-day average ($4.77) and -11.2% vs its 200-day average ($4.71).
- 52-week range $3.71–$7.75; today's close sits at 12% of that range, 46.1% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 — COYA slides 7.0% to $4.47, 3 down days in a row
- Closed at $4.47, -6.96% vs the prior close of $4.81. Day range $4.45–$4.89, opened at $4.81.
- Volume was 207.00K shares, 1.6x its 50-day average of 127.21K.
- Price is -6.4% vs its 50-day average ($4.78) and -5.1% vs its 200-day average ($4.72).
- 52-week range $3.71–$7.75; today's close sits at 19% of that range, 42.3% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — COYA dips 2.8% to $4.81
- Closed at $4.81, -2.83% vs the prior close of $4.95. Day range $4.81–$5.05, opened at $5.00.
- Volume was 102.10K shares, 0.8x its 50-day average of 128.76K.
- Price is +0.7% vs its 50-day average ($4.78) and +1.9% vs its 200-day average ($4.72).
- 52-week range $3.71–$7.75; today's close sits at 27% of that range, 37.9% below the 52-week high.
Oct 9, 2026 — COYA dips 0.8% to $4.95
- Closed at $4.95, -0.80% vs the prior close of $4.99. Day range $4.85–$5.05, opened at $5.00.
- Volume was 151.80K shares, 1.2x its 50-day average of 128.76K.
- Price is +3.9% vs its 50-day average ($4.77) and +4.8% vs its 200-day average ($4.72).
- 52-week range $3.71–$7.75; today's close sits at 31% of that range, 36.1% below the 52-week high.
Oct 8, 2026 — COYA rises 1.6% to $4.99
- Closed at $4.99, +1.63% vs the prior close of $4.91. Day range $4.70–$5.00, opened at $4.91.
- Volume was 144.20K shares, 1.1x its 50-day average of 128.76K.
- Price is +5.1% vs its 50-day average ($4.75) and +5.6% vs its 200-day average ($4.73).
- 52-week range $3.71–$7.75; today's close sits at 32% of that range, 35.6% below the 52-week high.
Oct 7, 2026 — COYA rises 1.2% to $4.91
- Closed at $4.91, +1.24% vs the prior close of $4.85. Day range $4.76–$5.01, opened at $4.81.
- Volume was 95.50K shares, 0.7x its 50-day average of 130.91K.
- Price is +3.9% vs its 50-day average ($4.73) and +3.8% vs its 200-day average ($4.73).
- 52-week range $3.71–$7.75; today's close sits at 30% of that range, 36.6% below the 52-week high.
Oct 6, 2026 — COYA ends flat (+0.0%) to $4.85
- Closed at $4.85, +0.00% vs the prior close of $4.85. Day range $4.74–$5.03, opened at $4.86.
- Volume was 94.60K shares, 0.7x its 50-day average of 130.64K.
- Price is +3.0% vs its 50-day average ($4.71) and +2.5% vs its 200-day average ($4.73).
- 52-week range $3.71–$7.75; today's close sits at 28% of that range, 37.4% below the 52-week high.
Oct 5, 2026 — COYA rises 0.8% to $4.85
- Closed at $4.85, +0.83% vs the prior close of $4.81. Day range $4.78–$4.94, opened at $4.85.
- Volume was 116.90K shares, 0.9x its 50-day average of 131.49K.
- Price is +3.3% vs its 50-day average ($4.70) and +2.4% vs its 200-day average ($4.73).
- 52-week range $3.71–$7.75; today's close sits at 28% of that range, 37.4% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 — COYA rises 1.7% to $4.81
- Closed at $4.81, +1.69% vs the prior close of $4.73. Day range $4.76–$4.93, opened at $4.80.
- Volume was 88.70K shares, 0.7x its 50-day average of 134.58K.
- Price is +2.7% vs its 50-day average ($4.68) and +1.5% vs its 200-day average ($4.74).
- 52-week range $3.71–$7.75; today's close sits at 27% of that range, 37.9% below the 52-week high.
COYA bull case vs bear case (from the data)
- Annual revenue grew 123.6% in the latest fiscal year (SEC XBRL).
- Price is -9.0% vs its 50-day average — short-term trend is down.
- Price is -7.8% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $21.23M.
- Share count up 40.3% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
COYA latest news & SEC filings
Every SEC filing by or about COYA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $243.75K (prior year $163.62K) (+49.0% vs Jun 30, 2025)
- Net income: -$6.64M (prior year -$6.09M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.28 (prior year -$0.36) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 27, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade COYA
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 16, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.79% (largest 7.1%).
- Liquidity: about 136.59K shares (≈$590.75K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.32 vs a range of $3.71–$7.55 (16% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 5, 2026; 8-K Sep 15, 2026.
- Share count: 23.46M shares outstanding (Aug 7, 2026), +40.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
COYA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 4.29 | 4.53 | 4.26 | 4.32 | 31.41K |
| Oct 16, 2026 | 4.37 | 4.39 | 4.16 | 4.25 | 134.20K |
| Oct 15, 2026 | 4.18 | 4.50 | 4.14 | 4.34 | 236.50K |
| Oct 14, 2026 | 4.64 | 4.64 | 4.16 | 4.18 | 258.00K |
| Oct 13, 2026 | 4.81 | 4.89 | 4.45 | 4.47 | 207.00K |
| Oct 12, 2026 | 5.00 | 5.05 | 4.81 | 4.81 | 102.10K |
| Oct 9, 2026 | 5.00 | 5.05 | 4.85 | 4.95 | 151.80K |
| Oct 8, 2026 | 4.91 | 5.00 | 4.70 | 4.99 | 144.20K |
| Oct 7, 2026 | 4.81 | 5.01 | 4.76 | 4.91 | 95.50K |
| Oct 6, 2026 | 4.86 | 5.03 | 4.74 | 4.85 | 94.60K |
| Oct 5, 2026 | 4.85 | 4.94 | 4.78 | 4.85 | 116.90K |
| Oct 2, 2026 | 4.80 | 4.93 | 4.76 | 4.81 | 88.70K |
| Oct 1, 2026 | 5.00 | 5.00 | 4.70 | 4.73 | 116.10K |
| Sep 30, 2026 | 5.06 | 5.15 | 4.98 | 5.01 | 101.40K |
| Sep 29, 2026 | 5.02 | 5.05 | 4.93 | 5.03 | 75.50K |
| Sep 28, 2026 | 5.03 | 5.12 | 4.96 | 4.98 | 120.20K |
| Sep 25, 2026 | 5.19 | 5.24 | 5.02 | 5.08 | 59.90K |
| Sep 24, 2026 | 5.02 | 5.18 | 4.92 | 5.18 | 105.10K |
| Sep 23, 2026 | 5.31 | 5.31 | 4.90 | 5.04 | 158.60K |
| Sep 22, 2026 | 4.99 | 5.35 | 4.93 | 5.30 | 334.10K |
About Coya Therapeutics
Coya Therapeutics (COYA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HOUSTON, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1835022.
COYA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Howard Berman | Executive Chairman | Jan 26, 2026 |
| Dov A Md Goldstein | Director | Jan 6, 2026 |
| Ann Lee | Director | Jan 6, 2026 |
| Mark H Pavao | Director | Apr 9, 2026 |
| Wilbur L Jr Ross | Director | Jan 6, 2026 |
| Arun Swaminathan | Chief Executive Officer | Jan 26, 2026 |
| Anabella Villalobos | Director | Jan 6, 2026 |
| Dieter Weinand | Director | Jan 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Howard Berman | Executive Chairman | Jan 26, 2026 |
| Fred Grossman | Chief Medical Officer | Jan 26, 2026 |
| David S Snyder | Chief Financial Officer | Jan 26, 2026 |
| Arun Swaminathan | Chief Executive Officer | Jan 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
COYA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $7.95M | $-21.23M | -1.27 | $-10.74M |
| Dec 31, 2024 | $3.55M | $-14.88M | -0.98 | $-10.29M |
| Dec 31, 2023 | $6.00M | $-7.99M | -0.79 | $-11.19M |
| Dec 31, 2022 | $0 | $-12.24M | -4.73 | $-7.24M |
| Dec 31, 2021 | — | $-4.89M | -1.89 | $-3.90M |
Latest balance sheet: total assets $47.31M, total liabilities $4.03M, cash $43.18M (as of Jun 30, 2026).
COYA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $4.80 |
| May 12, 2026 | 8-K Item 2.02 (results) | $4.29 |
| Mar 16, 2026 | 8-K Item 2.02 (results) | $4.50 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $6.09 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $6.13 |
| May 13, 2025 | 8-K Item 2.02 (results) | $5.76 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $6.45 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $7.26 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 19, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on COYA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.